Literature DB >> 6288939

Pretreatment with phorbol myristate acetate inhibits macrophage activity against intracellular protozoa.

H W Murray.   

Abstract

To further document the role of toxic oxygen intermediates in mononuclear phagocyte antiprotozoal activity, microbicidal macrophages were depleted of the capacity to generate superoxide anion (O-2) and hydrogen peroxide (H2O2) by pretreatment with phorbol myristate acetate (PMA), a soluble agent which triggers the macrophage respiratory burst. Treating cells for 90 min with 200 ng/ml of PMA inhibited the extracellular release of both O-2 and H2O2 by 90% upon subsequent restimulation with either PMA or opsonized zymosan. This effect persisted for 48 h, and could not be reversed by the addition of lymphokine. Intracellular nitro-blue tetrazolium reduction by PMA-treated cells was also inhibited by 66-95% upon rechallenge with either PMA or inert or viable particulate agents. In parallel, PMA pretreatment abolished or markedly impaired the ability of normal, lymphokine-stimulated, and in vivo activated macrophages to kill three diverse protozoa--Toxoplasma gondii, Leishmania donovani, and Trypanosoma cruzi. These studies illustrate an additional technique for investigating the antiprotozoal effects of macrophage-derived O-2 and H2O2 and reemphasize the importance of an intact respiratory burst mechanism in killing of intracellular parasites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288939

Source DB:  PubMed          Journal:  J Reticuloendothel Soc        ISSN: 0033-6890


  23 in total

1.  Oxidative stress fuels Trypanosoma cruzi infection in mice.

Authors:  Claudia N Paiva; Daniel F Feijó; Fabianno F Dutra; Vitor C Carneiro; Guilherme B Freitas; Letícia S Alves; Jacilene Mesquita; Guilherme B Fortes; Rodrigo T Figueiredo; Heitor S P Souza; Marcelo R Fantappié; Joseli Lannes-Vieira; Marcelo T Bozza
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 2.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

3.  Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis.

Authors:  Ranadhir Dey; Arup Sarkar; Nivedita Majumder; Suchandra Bhattacharyya Majumdar; Kaushik Roychoudhury; Sandip Bhattacharyya; Syamal Roy; Subrata Majumdar
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Immune-complex inhibition of macrophage activation is not due to an interaction with the binding or processing of IFN-gamma.

Authors:  A Celada
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

5.  Oxygen-dependent leishmanicidal activity of stimulated macrophages.

Authors:  R Chakraborty; S Mukherjee; M K Basu
Journal:  Mol Cell Biochem       Date:  1996-01-12       Impact factor: 3.396

6.  Effect of phorbol-12-myristate-13-acetate (PMA) on the fine structure of Trypanosoma cruzi and its interaction with activated and resident macrophages.

Authors:  T U de Carvalho; W de Souza
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

7.  Role of iron in intracellular growth of Trypanosoma cruzi.

Authors:  V G Loo; R G Lalonde
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Entamoeba histolytica stimulates the unstable transcription of c-fos and tumour necrosis factor-alpha mRNA by protein kinase C signal transduction in macrophages.

Authors:  R Seguin; K Keller; K Chadee
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

Review 9.  The role of free oxygen radicals in the expulsion of primary infections of Nippostrongylus brasiliensis.

Authors:  N C Smith
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

10.  Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp.

Authors:  Y Buchmüller-Rouiller; J Mauël
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.